Enfusion Inc.

Who owns Enfusion?

Enfusion Inc. was acquired by Clearwater Analytics Holdings in 2025 for approximately $1.5 billion. The transaction closed in April 2025. Before the acquisition, Enfusion was a publicly traded company listed on the New York Stock Exchange under the ticker ENFN. Clearwater Analytics trades on the NYSE under the ticker CWAN.

What does Enfusion do?

Enfusion provides a cloud-native software platform for investment managers. The system covers portfolio management, order and execution management, risk analytics, and fund accounting on a single data set. The company also offers managed services where Enfusion staff handle middle and back office operations for clients. Over 900 investment managers use the platform.

When was Enfusion founded?

Enfusion was founded in 1997 as a technology and operations consulting firm. The founders, Tarek Hammoud, Stephen Malherbe, and Scott Werner, launched the flagship software platform in 2006. The company went public on the New York Stock Exchange in October 2021 under the ticker ENFN.

How much revenue does Enfusion generate?

Enfusion reported $201.6 million in total revenue for fiscal 2024, up 15.5% from $174.5 million in fiscal 2023. Gross profit margin was 67.8% and adjusted EBITDA margin was 21.2%. Net income margin was 1.9%, down from 5.3% in the prior year. Revenue figures are reported on a calendar year fiscal basis ending December 31.

Is Enfusion the same as Clearwater Analytics?

No, but the two companies are now combined. Clearwater Analytics acquired Enfusion in 2025. Enfusion operates as a subsidiary and its products are marketed alongside Clearwater's investment accounting platform under the CWAN brand. The Enfusion name remains in use for the investment management software product line.

How many employees does Enfusion have?

Enfusion employs approximately 574 people as of 2025. The workforce is distributed across 12 countries, with offices in the United States, the United Kingdom, Ireland, Hong Kong, Singapore, India, and other locations. The employee count declined following the Clearwater acquisition due to restructuring.

Where is Enfusion headquartered?

Enfusion is headquartered at 125 South Clark Street, Suite 750, Chicago, Illinois 60603. The company maintains additional offices in New York, London, Dublin, Hong Kong, Mumbai, Singapore, and Sao Paulo. The Chicago office serves as the principal corporate location.

Enfusion began in 1997 as a technology and operations consulting firm. The founders, Tarek Hammoud, Stephen Malherbe, and Scott Werner, met while working in technology roles at large hedge funds. They saw that investment managers struggled with fragmented systems, patched-together platforms, and inefficient workflows. The consulting business helped financial firms customize off-the-shelf software that could not meet their requirements out of the box.

After years of consulting work, the founders decided to build their own platform. In 2006 they launched Integrata, the product that became the Enfusion platform. The system was designed from the start as a cloud-native, multi-tenant application, years before cloud computing became standard in financial services. It combined portfolio management, a general ledger, and an order and execution management system on a single data set.

The company grew its client base through the 2010s. It raised private capital to fund expansion. FTV Capital led a private equity round in 2017, and ICONIQ Growth led a $150 million round in January 2021. Total funding reached approximately $256 million across private rounds and post-IPO debt.

Enfusion completed its initial public offering on the New York Stock Exchange in October 2021, trading under the ticker ENFN. The IPO gave the company public market capital and liquidity for early investors. At the time of the IPO, the company served approximately 635 investment management clients.

In January 2025, Clearwater Analytics Holdings agreed to acquire Enfusion for approximately $1.5 billion. The acquisition closed in April 2025. Clearwater Analytics, itself a publicly traded financial technology company, integrated Enfusion into a broader platform covering the investment lifecycle for asset managers. Following the acquisition, Enfusion operates as part of Clearwater Analytics and is marketed under the CWAN brand on LinkedIn and in corporate communications.

Enfusion publishes limited standalone sustainability disclosures following the Clearwater acquisition. As a software company, its direct environmental footprint is small, consisting primarily of office energy use and cloud infrastructure consumption. The company does not operate manufacturing facilities or produce physical goods.

The more significant ethical dimension of Enfusion's business is data security and client confidentiality. Investment managers entrust Enfusion with portfolio holdings, trade data, and fund accounting records. A breach could expose sensitive positions and strategies. The company invests in cybersecurity controls, encryption, and access management to protect client data. Its cybersecurity rating from third-party assessors is a factor that institutional clients evaluate during vendor selection.

Following the Clearwater acquisition, sustainability reporting is consolidated at the Clearwater Analytics parent level. Clearwater publishes environmental, social, and governance disclosures that cover the combined organization, including Enfusion operations.